TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $96,140 | -66.3% | 11,500 | 0.0% | 0.09% | -64.9% |
| Q2 2023 | $285,660 | +65.2% | 11,500 | 0.0% | 0.26% | +58.9% |
| Q1 2023 | $172,960 | +27.1% | 11,500 | 0.0% | 0.16% | +19.9% |
| Q4 2022 | $136,045 | +70.1% | 11,500 | -14.8% | 0.14% | +78.9% |
| Q3 2022 | $80,000 | +40.4% | 13,500 | 0.0% | 0.08% | +31.0% |
| Q2 2022 | $57,000 | -58.7% | 13,500 | -6.9% | 0.06% | -53.6% |
| Q1 2022 | $138,000 | -50.0% | 14,500 | 0.0% | 0.12% | -48.6% |
| Q4 2021 | $276,000 | -42.9% | 14,500 | 0.0% | 0.24% | -43.0% |
| Q3 2021 | $483,000 | -14.1% | 14,500 | 0.0% | 0.43% | -13.4% |
| Q2 2021 | $562,000 | – | 14,500 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |